AI assistant
ANAPTYSBIO, INC — Director's Dealing 2024
Jan 10, 2024
32596_dirs_2024-01-09_8dcc4081-f666-4574-b6e4-3e75a83a13a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2024-01-06
Reporting Person: LOUMEAU ERIC J (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-06 | Common Stock | M | 5545 | $0.00 | Acquired | 5545 | Direct |
| 2024-01-08 | Common Stock | S | 2305 | $21.81 | Disposed | 3240 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-06 | Restricted Stock Unit | $ | M | 5545 | Disposed | Common Stock (5545) | Direct |
Footnotes
F1: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.